The objective of this review was the analysis of the role of lipid metabolism disorders in the pathogenesis of the comorbid course of COPD and atherosclerosis and the participation of representatives of ABC transporters in these processes. This evidence concerns the gene ABCG2 and chronic obstructive pulmonary disease.